Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Pohl

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Insights Into Imaging|July 19, 2020
Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesionsVijay Sawlani, Markand Dipankumar Patel, Nigel Davies, et al.
Neuro-Oncology Practice|September 21, 2022
Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgeryRosa Sun, Shivam Sharma, Helen Benghiat, et al.
Cancer Research|April 3, 2003
Gene expression-based classification of malignant gliomas correlates better with survival than histological classificationCatherine L Nutt, D R Mani, Rebecca A Betensky, et al.
The Journal of Pathology|February 2, 2022
Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytesSandra Gray-Rodriguez, Melanie P Jensen, Maria Otero-Jimenez, et al.
Brain : a Journal of Neurology|October 31, 2012
Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristicsRobert D S Pitceathly, Conrad Smith, Carl Fratter, et al.
Acta Neuropathologica|December 30, 2021
Oligosarcomas, IDH-mutant are distinct and aggressiveAbigail K Suwala, Marius Felix, Dennis Friedel, et al.
Neuro-Oncology|January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutantEmilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Acta Neuropathologica Communications|October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entitiesAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|March 23, 2018
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterationsAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Insights Into Imaging|July 19, 2020
Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesionsVijay Sawlani, Markand Dipankumar Patel, Nigel Davies, et al.
Neuro-Oncology Practice|September 21, 2022
Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgeryRosa Sun, Shivam Sharma, Helen Benghiat, et al.
Cancer Research|April 3, 2003
Gene expression-based classification of malignant gliomas correlates better with survival than histological classificationCatherine L Nutt, D R Mani, Rebecca A Betensky, et al.
The Journal of Pathology|February 2, 2022
Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytesSandra Gray-Rodriguez, Melanie P Jensen, Maria Otero-Jimenez, et al.
Brain : a Journal of Neurology|October 31, 2012
Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristicsRobert D S Pitceathly, Conrad Smith, Carl Fratter, et al.
Acta Neuropathologica|December 30, 2021
Oligosarcomas, IDH-mutant are distinct and aggressiveAbigail K Suwala, Marius Felix, Dennis Friedel, et al.
Neuro-Oncology|January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutantEmilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Acta Neuropathologica Communications|October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entitiesAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|March 23, 2018
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterationsAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Pageof 5